Upgrade to SI Premium - Free Trial

Leerink Starts Pacira Pharmaceuticals (PCRX) at Market Perform

September 9, 2026 6:10 AM
Leerink analyst Daniel Clark initiates coverage on Pacira Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage